Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency TrendingStockAlerts · Jul 21, 2025
Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis TrendingStockAlerts · Jul 20, 2025
SERM Market Shows Promising Growth Trajectory During the Study Period (2020-2034) Owing to the Rising Demand in Oncology and Women's Health | DelveInsight TrendingStockAlerts · Jul 19, 2025
Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results TrendingStockAlerts · Jul 18, 2025
The drug discovery research for lecanemab awarded the 9th Bioindustry Award by the Japan Bioindustry Association TrendingStockAlerts · Jul 17, 2025
Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society's Annual Meeting TrendingStockAlerts · Jul 16, 2025
Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot TrendingStockAlerts · Jul 15, 2025
WuXi AppTec Issues Positive Profit Alert for the First Half of 2025 TrendingStockAlerts · Jul 14, 2025
Bio Investments Group (BIG) and International Vaccine Institute (IVI) Forge Partnership to Accelerate Vaccine Self-Reliance in Africa and the Middle East TrendingStockAlerts · Jul 13, 2025
Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight TrendingStockAlerts · Jul 12, 2025
Angel Yeast Unveils 2024 Sustainability Report, Showcasing Commitment to Green Practices and Innovation TrendingStockAlerts · Jul 11, 2025
Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2025 Financial Results TrendingStockAlerts · Jul 10, 2025
